Jeff Yass’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.77M Buy
142,315
+72,210
+103% +$4.1M ﹤0.01% 3450
2026
Q1
$4.5M Buy
70,105
+58,441
+501% +$5.33M ﹤0.01% 4424
2025
Q4
$1.52M Sell
11,664
-112,874
-91% -$15.5M ﹤0.01% 6217
2025
Q3
$13.4M Buy
124,538
+99,632
+400% +$10.9M ﹤0.01% 2645
2025
Q2
$2.3M Sell
24,906
-463
-2% -$36.3K ﹤0.01% 5504
2025
Q1
$2.25M Buy
25,369
+19,213
+312% +$1.67M ﹤0.01% 5265
2024
Q4
$473K Sell
6,156
-7,356
-54% -$514K ﹤0.01% 8804
2024
Q3
$573K Buy
+13,512
New +$456K ﹤0.01% 8133
2023
Q2
Sell
-5,737
Closed -$45.4K 13266
2023
Q1
$69.1K Buy
5,737
+3,621
+171% +$48.3K ﹤0.01% 11535
2022
Q4
$18.4K Sell
2,116
-2,105
-50% -$46.4K ﹤0.01% 11790
2022
Q3
$122K Buy
4,221
+1,837
+77% +$84.1K ﹤0.01% 11501
2022
Q2
$99K Sell
2,384
-28,974
-92% -$1.97M ﹤0.01% 11492
2022
Q1
$3.18M Buy
31,358
+19,870
+173% +$2.21M ﹤0.01% 4516
2021
Q4
$1.69M Buy
11,488
+3,888
+51% +$869K ﹤0.01% 5906
2021
Q3
$1.9M Sell
7,600
-4,363
-36% -$1.5M ﹤0.01% 5944
2021
Q2
$5.53M Buy
+11,963
New +$5.14M ﹤0.01% 3859

Other funds holding WGS

Jeff Yass's WGS Position: Q2 2026 in Review

Jeff Yass increased its GeneDx Holdings (WGS) stake by 103% in Q2 2026, buying an estimated $4.1M and bringing the position to 142,315 shares worth $9.77M. The position accounts for ﹤0.01% of the portfolio, ranked #3450.

Jeff Yass first reported a position in WGS in Q2 2021 and has held it in 16 quarters since. The position peaked at $13.4M in Q3 2025. 222 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Jeff Yass held 142,315 shares of GeneDx Holdings worth $9.77M as of Q2 2026.
  • Jeff Yass bought 72,210 GeneDx Holdings shares in Q2 2026, an estimated $4.1M.
  • GeneDx Holdings made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #3450 holding.
  • Jeff Yass first reported a position in GeneDx Holdings in Q2 2021 and has held it in 16 quarters since.
  • Jeff Yass's GeneDx Holdings position peaked at $13.4M in Q3 2025.
  • 222 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.